• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 25VAVGJ-515
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Hemoptysis (1887); Hemorrhage/Bleeding (1888); Intracranial Hemorrhage (1891)
Event Date 12/10/2022
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Clinical information: crd_992 - valved grafts pas, patient site id: us0172-855, r731666301, r731672401, r731803601.It was reported that on (b)(6) 2022, a 25mm sjm masters series valsalva aortic valved graft was successfully implanted in a patient with a history of kidney disease and a kidney transplant.On (b)(6) 2022, the patient was noted to be suffering from worsening kidney disease, the patient's baseline creatine levels were as follows, on (b)(6) 2022: 2.33 mg/dl and progressed to 2.98 mg/dl, and on (b)(6) 2023 = 2.93 mg/dl.This event resulted in hospitalization of the patient.On (b)(6) 2022, the patient developed sternal chest pain and an onset of hemoptysis.The patient was suffering from tachypnea, the patient became increasingly in need of oxygen.The patient had filled a basin with 100ml of a mix of blood and sputum.The patient's heparin infusion was then withheld.A chest x-ray revealed bilateral infiltrates.The patient was transferred to the intensive care unit.A laryngoscopy was performed and found no active bleeding of the upper airway.On (b)(6) 2022, the patient was noted the have an altered mental status.A computed tomography scan was performed and discovered that the patient was suffering from an intraparenchymal hemorrhage within the left parietal lobe, with a surrounding edema.Additionally, a subarachnoid hemorrhage was noted along the sulci in the left and right occipitoparietal lobes.There were no new large ischemic changes noted.The patient was taken back to the intensive care unit (icu) and monitored and neurological check ups.The patient was still in the icu on (b)(6) 2023, but alert and oriented.There was no treatment performed for either event.The bleeding is believed to be attributed to the anticoagulation from administration of heparin and warfarin, but without clear etiology.
 
Event Description
Subsequent to the previously filed report, additional information was received: the bilateral infiltrates detected via chest x-ray, were pleural effusions and possibly pulmonary edemas.The patient's worsening kidney disease is believed to be attributed to the patient's past medical history.On (b)(6) 2022, the patient was transfused 1 unit packed red blood cells (prbc) due to a hemoglobin of 6.7.On (b)(6) 2022, the patient was again transfused 1 unit prbc due to a hemoglobin of 5.9there was no allegation of malfunction against the 25mm sjm masters series valsalva aortic valved graft or procedure.The patient was reported to have been discharged home.
 
Manufacturer Narrative
An event of acute kidney failure, hemoptysis, angina, bleeding, and intracranial hemorrhage was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.There is no indication of a product quality issue with respect to the labeling design or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC. REG#2648612
20 b st caguas west park
caguas 00725
*   00725
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16277601
MDR Text Key308573364
Report Number2135147-2023-00349
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier05414734009492
UDI-Public05414734009492
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/01/2023
Device Model Number25VAVGJ-515
Device Catalogue Number25VAVGJ-515
Device Lot Number7925036
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age33 YR
Patient SexFemale
Patient Weight63 KG
Patient RaceBlack Or African American
-
-